Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial Testing Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma

NCT00669136 is registered in ClinicalTrials.gov with Lisa H. Butterfield, Ph.D. as lead sponsor.

NCT NCT00669136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00669136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial Testing Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
Lead sponsor
Lisa H. Butterfield, Ph.D.
Phase
Phase 1
Overall status
Terminated
Start date
June 30, 2009
Completion date
March 31, 2013
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of liver, cancer of the liver, cancer, hepatocellular, hepatic cancer, hepatic neoplasms, hepatocellular cancer, hepatocellular carcinoma, hepatoma, liver cancer, liver cancer, adult, liver cell carcinoma, liver cell carcinoma, adult, neoplasms, hepatic, neoplasms, liver